本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Avidity Biosciences, Inc.

47.23
+0.65001.40%
盤後47.980.7497+1.59%19:55 EDT
成交量:303.24萬
成交額:1.42億
市值:60.76億
市盈率:-13.24
高:47.63
開:47.42
低:45.24
收:46.58
52周最高:56.00
52周最低:21.51
股本:1.29億
流通股本:9,981.53萬
量比:1.56
換手率:3.04%
股息:- -
股息率:- -
每股收益(TTM):-3.5671
每股收益(LYR):-2.8885
淨資產收益率:-37.76%
總資產收益率:-24.01%
市淨率:5.09
市盈率(LYR):-16.35

資料載入中...

2025/03/25

重要事件披露

Form 8-K - Current report
2025/03/17

重要事件披露

Form 8-K - Current report
2025/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities